Future Leaders in Huntington’s Disease Research

About the Speakers

Hassan Fakih, PhD
University of Massachusetts Chan Medical School

Dr. Fakih focuses on enhancing the extra-hepatic delivery of siRNA therapeutics. He employs self-assembled nucleic acid particles and lipophilic conjugation strategies to precisely control protein binding and siRNA pharmacokinetics. Ultimately, Dr. Fakih aims to develop effective siRNA-based therapeutics for muscle diseases (e.g., wasting, aging), oncology, and CNS disorders.

Icnelia Huerto Ocampo, MD, PhD
The Children’s Hospital of Philadelphia

Dr. Icnelia Huerta, in the Davidson Lab, works on neurodegenerative diseases using a translational approach. Her current research focuses on developing gene therapy strategies aimed at improving treatment options for disorders of the basal ganglia, including Huntington’s disease. She is passionate about advancing therapies that can ultimately improve the quality of life for patients and families affected by these conditions.

Xiaojing Sui, PhD
Northwestern University

Dr. Sui has studied Huntington’s disease throughout her career, using a multidisciplinary approach to uncover how proteome conformational instability drives aging and neurodegenerative diseases. Her work aims to define the molecular principles of proteome maintenance and identify strategies to restore proteostasis and resilience in aging and disease. She was recently recognized as a Rising Star in Proteomics and Metabolomics by the American Chemical Society for her innovative contributions to quantitative structural proteomics.

Thank you to our webinar sponsors: